Title : Prodigiosin inhibits Wnt/β-catenin signaling and exerts anticancer activity in breast cancer cells.

Pub. Date : 2016 Nov 15

PMID : 27799526






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Prodigiosin blocked Wnt/beta-catenin signaling by targeting multiple sites of this pathway, including the low-density lipoprotein-receptor-related protein (LRP) 6, Dishevelled (DVL), and glycogen synthase kinase-3beta (GSK3beta). Prodigiosin glycogen synthase kinase 3 beta Homo sapiens
2 Prodigiosin blocked Wnt/beta-catenin signaling by targeting multiple sites of this pathway, including the low-density lipoprotein-receptor-related protein (LRP) 6, Dishevelled (DVL), and glycogen synthase kinase-3beta (GSK3beta). Prodigiosin glycogen synthase kinase 3 beta Homo sapiens
3 In breast cancer MDA-MB-231 and MDA-MB-468 cells, nanomolar concentrations of prodigiosin decreased phosphorylation of LRP6, DVL2, and GSK3beta and suppressed beta-catenin-stimulated Wnt target gene expression, including expression of cyclin D1. Prodigiosin glycogen synthase kinase 3 beta Homo sapiens